期刊文献+

ICU院内感染原因分析及护理对策 被引量:7

Causes and nursing measures of nosocomial infections in intensive care units
原文传递
导出
摘要 目的探讨重症监护室(ICU)院内感染的相关因素,有效预防和控制院内感染的发生。方法对2011年7月至2012年12月ICU院内感染240例患者进行分析。结果 ICU院内感染中以老年患者居多,感染部位以切口感染、下呼吸道、泌尿道、血液常见,疾病以重型颅脑损伤、脑出血、高血压危象、脑出血、胆道疾患、腹膜炎感染最高,并与机械通气、创伤性操作、医务人员缺乏交叉感染意识、没有严格执行无菌技术操作原则、机体抵抗力下降、不合理使用抗生素有关。结论加强ICU管理、改善环境因素、减少医源性危险因素的产生和损伤、提高机体抵抗力、合理使用抗生素等是预防ICU院内感染的有效措施。 Objective To explore the causes of nosocomial infections in intensive care unit( ICU) so as to take the countermeasures for reducing the nosocomial infections effectively. Methods A retrospective investigation was performed for 240 patients in ICU from July,2011 to December,2012. Results The senile patients with nosocomial infections were of the majority. The common locations of the infections included lower respiratory tract,incision,and urinary tract. The common diseases included heavy craniocerebral injury,hypertensive crisis,encephalorrhagia,biliary tract disease,and peritonitis. The incidence was related to traumatic manipulation,mechanical ventilation,no consciousness of cross infection and not strict execution of sterile operation,the decline of the immunity of patients,and inappropriate antibiotic use. Conclusions Strengthening the management of ICU,improving the environment,reducing the iatrogenic risk factors,improving body immunity,and using antibiotic appropriately are the main measures for preventing bacterial infections in ICU.
作者 许绵绵
出处 《中国校医》 2014年第11期803-805,共3页 Chinese Journal of School Doctor
关键词 加强医疗病房 交叉感染/病因学 交叉感染/预防和控制 护理工作 Intensive Care Units Cross Infections/etiology Cross Infections/prevention and control Nursing Care
  • 相关文献

参考文献6

二级参考文献18

  • 1田洪明,舒逸平,王莉.擦手毛巾染菌量与潜在医源性感染分析[J].中华医院感染学杂志,1996,6(3):162-163. 被引量:28
  • 2Craig WA. Pharmacokinetic/Pharmacyodynamic parameters:rationale for antibacterial dosing of mice and men[J]. Clin Infect Dis, 1998,26:1-10.
  • 3Zhanel GG. Influence of pharmacyokinetic and pharmacodynamic Principles on Antibiotic Selection[J]. Curr Infect Dis Rep, 2001,3: 29-34.
  • 4Tulkens PM. New strategies to avoid development of microbial resistance[C]. A symposium on resistance and the use and misuse of antimicrobial therapy, 2000,44-52.
  • 5Maglio D, Nightingale CH, Nicolau DP. Extended interval aminoglycoside dosing : from concept to clinic[J]. Int J Antimicrob Agents, 2002,19 : 341-348.
  • 6Prins JM, Speelman P. Once daily aminoglycosides: practical guideline[J]. Neth J Med, 1998,52 : 1-9.
  • 7Hierholzer WJ,Garner JS, Adams AB, et al. Recommendations for preventing the spread of vancomycin resistance:Recommendations of the HICPAC[J]. Am J Infect Control, 1995,23: 87-94.
  • 8HICPAC. Interim guidelines for prevention and control of staphylococcal infection associated with reduced susceptibility to vancomycin[J]. Morb Mortal Wkly Rep,2002,51:565-567.
  • 9Schaad UB,Abdus Salam M,Aujard Y,et al. Use of fluoroquinolones in pediatrics : Consensus report of an International Society of Chemotherapy commission[J]. Pediatr Infect Dis J, 1995,14:1-9.
  • 10Schaad UB, Wedgwood J. Lack of quinolone-induced arthropathy in children[J]. J Antimicrob Chemother, 1992,30:414-416.

共引文献201

同被引文献50

引证文献7

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部